Biotechnology Assets Osake

Biotechnology Assets EBITDA

EBITDA (Tulos ennen korkoja, veroja ja poistoja) yhtiöstä Biotechnology Assets (BST.MC) 4.8.2026 päivämäärällä on −1,90 M EUR. Edellisenä vuonna EBITDA (Tulos ennen korkoja, veroja ja poistoja) oli 4,27 M EUR — muutos −144,53 % (matalampi).

EBITDA

−1,90 MEUR

YoY

−144,53%

Viimeksi päivitetty:

EBITDA (Tulos ennen korkoja, veroja ja poistoja) yhtiöstä Biotechnology Assets on 2026 −1,90 M EUR. EBITDA (Tulos ennen korkoja, veroja ja poistoja) yhtiöstä Biotechnology Assets oli 2025 4,27 M EUR. Se laskee −144,53% matalampi edelliseen vuoteen verrattuna.
Access this data via the Eulerpool API

Biotechnology Assets Osakeanalyysi

Mitä Biotechnology Assets tekee? ADL Bionatur Solutions SA is a Swiss company specializing in the development and production of natural ingredients for the food, cosmetics, and pharmaceutical industries. The company was founded in 2000 and has since had an impressive success story. ADL Bionatur Solutions SA's business model is based on the use of plants and microorganisms to extract high-quality natural active ingredients. The company employs environmentally friendly methods and sustainable production practices that meet the needs of society and nature alike. One of ADL Bionatur Solutions SA's main sectors is the production of natural flavors and colorants for the food industry. Depending on customer preferences, color pigments are extracted from fruits, vegetables, or other plants to color food products with natural ingredients. Natural flavors are also isolated using plant extracts and other natural sources. These products are particularly sought after because they are not only healthier than synthetic alternatives but also provide consumers with a better feeling. Another significant sector of ADL Bionatur Solutions SA is the development of cosmetics based on natural ingredients. For example, extracts from algae, flowers, or herbs are used to create skincare products that are gentle on the skin while still being highly effective. Products targeting signs of aging or acne are also based on natural ingredients from ADL Bionatur Solutions SA. In addition to these two main sectors, ADL Bionatur Solutions SA also offers products for the pharmaceutical industry. The company focuses on developing active ingredients based on natural substances that can be used to treat various diseases. Sustainability is also a key focus here, as naturally derived active ingredients are not only healthier but also have a higher biological availability. In addition to these main sectors, ADL Bionatur Solutions SA provides consulting services to customers. This includes the development of tailored natural solutions and support for product certification according to the highest international standards. Overall, in recent years, ADL Bionatur Solutions SA has become one of the world's leading companies in the field of natural ingredients. With a wide portfolio of products and services and a strong focus on sustainability and environmental compatibility, the company is well-positioned to benefit from the ongoing trend towards natural and healthier products. Biotechnology Assets on yksi Eurpooliin suosituimmista yhtiöistä.

Usein kysytyt kysymykset Biotechnology Assets osakkeesta

Yhtiön Biotechnology Assets EBITDA (Tulos ennen korkoja, veroja ja poistoja) on −1,90 M EUR vuonna 2026.

EBITDA (Tulos ennen korkoja, veroja ja poistoja) yhtiöstä Biotechnology Assets muuttui arvosta 4,27 M EUR arvoon −1,90 M EUR, mikä edustaa −144,53 % muutosta. Arvo on matalampi kuin edellisenä vuonna.

Eurpoolissa voit löytää EBITDA (Tulos ennen korkoja, veroja ja poistoja) Biotechnology Assets:n täydellisen historiallisen kehityksen vuodesta 2006 lähtien – vuotuisten arvojen, kaavioiden ja yksityiskohtaisen analyysin kanssa.

EBITDA mittaa operatiivista suorituskykyä ennen rahoitusrakenteen, veroympäristön ja muiden kuin käteispoisto-osuuksien vaikutusta.

EBITDA = EBIT + Poistot

EBITDA (Tulos ennen korkoja, veroja ja poistoja):n EUR on sijoittajille tärkeä tekijä. Muutokset tässä tunnusluvussa voivat signaloida parantuvia tai heikentyneitä perustekijöitä, mikä vaikuttaa suoraan osakekurssiin. Eulerpoolissa voit seurata EBITDA (Tulos ennen korkoja, veroja ja poistoja):n Biotechnology Assets historiallisesti ja reaaliajassa.

Access this data via the Eulerpool API

Tuloslaskelma — Biotechnology Assets

Kaikki tunnusluvut — Biotechnology Assets